Report Detail
Global AT1 Receptor Antagonists Market Insights and Forecast to 2026
- RnM4132879 |
- 13 August, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
AT1 Receptor Antagonists market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global AT1 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the AT1 Receptor Antagonists market is segmented into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Segment by Application, the AT1 Receptor Antagonists market is segmented into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Regional and Country-level Analysis
The AT1 Receptor Antagonists market is analysed and market size information is provided by regions (countries).
The key regions covered in the AT1 Receptor Antagonists market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and AT1 Receptor Antagonists Market Share Analysis
AT1 Receptor Antagonists market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in AT1 Receptor Antagonists business, the date to enter into the AT1 Receptor Antagonists market, AT1 Receptor Antagonists product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
1 Study Coverage
- 1.1 AT1 Receptor Antagonists Product Introduction
- 1.2 Market Segments
- 1.3 Key AT1 Receptor Antagonists Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
- 1.4.2 Valsartan
- 1.4.3 Telmisartan
- 1.4.4 Losartan
- 1.4.5 Irbesartan
- 1.4.6 Azilsartan
- 1.4.7 Olmesartan
- 1.5 Market by Application
- 1.5.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Application
- 1.5.2 Hypertension
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Kidney Diseases
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global AT1 Receptor Antagonists Market Size, Estimates and Forecasts
- 2.1.1 Global AT1 Receptor Antagonists Revenue 2015-2026
- 2.1.2 Global AT1 Receptor Antagonists Sales 2015-2026
- 2.2 Global AT1 Receptor Antagonists, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global AT1 Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global AT1 Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global AT1 Receptor Antagonists Competitor Landscape by Players
- 3.1 AT1 Receptor Antagonists Sales by Manufacturers
- 3.1.1 AT1 Receptor Antagonists Sales by Manufacturers (2015-2020)
- 3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers (2015-2020)
- 3.2 AT1 Receptor Antagonists Revenue by Manufacturers
- 3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2015-2020)
- 3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by AT1 Receptor Antagonists Revenue in 2019
- 3.2.5 Global AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 AT1 Receptor Antagonists Price by Manufacturers
- 3.4 AT1 Receptor Antagonists Manufacturing Base Distribution, Product Types
- 3.4.1 AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers AT1 Receptor Antagonists Product Type
- 3.4.3 Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global AT1 Receptor Antagonists Market Size by Type (2015-2020)
- 4.1.1 Global AT1 Receptor Antagonists Sales by Type (2015-2020)
- 4.1.2 Global AT1 Receptor Antagonists Revenue by Type (2015-2020)
- 4.1.3 AT1 Receptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global AT1 Receptor Antagonists Market Size Forecast by Type (2021-2026)
- 4.2.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2021-2026)
- 4.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Type (2021-2026)
- 4.2.3 AT1 Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global AT1 Receptor Antagonists Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global AT1 Receptor Antagonists Market Size by Application (2015-2020)
- 5.1.1 Global AT1 Receptor Antagonists Sales by Application (2015-2020)
- 5.1.2 Global AT1 Receptor Antagonists Revenue by Application (2015-2020)
- 5.1.3 AT1 Receptor Antagonists Price by Application (2015-2020)
- 5.2 AT1 Receptor Antagonists Market Size Forecast by Application (2021-2026)
- 5.2.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2021-2026)
- 5.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Application (2021-2026)
- 5.2.3 Global AT1 Receptor Antagonists Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America AT1 Receptor Antagonists by Country
- 6.1.1 North America AT1 Receptor Antagonists Sales by Country
- 6.1.2 North America AT1 Receptor Antagonists Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America AT1 Receptor Antagonists Market Facts & Figures by Type
- 6.3 North America AT1 Receptor Antagonists Market Facts & Figures by Application
7 Europe
- 7.1 Europe AT1 Receptor Antagonists by Country
- 7.1.1 Europe AT1 Receptor Antagonists Sales by Country
- 7.1.2 Europe AT1 Receptor Antagonists Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe AT1 Receptor Antagonists Market Facts & Figures by Type
- 7.3 Europe AT1 Receptor Antagonists Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific AT1 Receptor Antagonists by Region
- 8.1.1 Asia Pacific AT1 Receptor Antagonists Sales by Region
- 8.1.2 Asia Pacific AT1 Receptor Antagonists Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific AT1 Receptor Antagonists Market Facts & Figures by Type
- 8.3 Asia Pacific AT1 Receptor Antagonists Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America AT1 Receptor Antagonists by Country
- 9.1.1 Latin America AT1 Receptor Antagonists Sales by Country
- 9.1.2 Latin America AT1 Receptor Antagonists Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America AT1 Receptor Antagonists Market Facts & Figures by Type
- 9.3 Central & South America AT1 Receptor Antagonists Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa AT1 Receptor Antagonists by Country
- 10.1.1 Middle East and Africa AT1 Receptor Antagonists Sales by Country
- 10.1.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa AT1 Receptor Antagonists Market Facts & Figures by Type
- 10.3 Middle East and Africa AT1 Receptor Antagonists Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer AT1 Receptor Antagonists Products Offered
- 11.1.5 Pfizer Related Developments
- 11.2 Novartis
- 11.2.1 Novartis Corporation Information
- 11.2.2 Novartis Description and Business Overview
- 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novartis AT1 Receptor Antagonists Products Offered
- 11.2.5 Novartis Related Developments
- 11.3 Merck
- 11.3.1 Merck Corporation Information
- 11.3.2 Merck Description and Business Overview
- 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Merck AT1 Receptor Antagonists Products Offered
- 11.3.5 Merck Related Developments
- 11.4 Astra Zeneca
- 11.4.1 Astra Zeneca Corporation Information
- 11.4.2 Astra Zeneca Description and Business Overview
- 11.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Astra Zeneca AT1 Receptor Antagonists Products Offered
- 11.4.5 Astra Zeneca Related Developments
- 11.5 Jhonson and Johnson
- 11.5.1 Jhonson and Johnson Corporation Information
- 11.5.2 Jhonson and Johnson Description and Business Overview
- 11.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Jhonson and Johnson AT1 Receptor Antagonists Products Offered
- 11.5.5 Jhonson and Johnson Related Developments
- 11.6 Eli Lilly
- 11.6.1 Eli Lilly Corporation Information
- 11.6.2 Eli Lilly Description and Business Overview
- 11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Eli Lilly AT1 Receptor Antagonists Products Offered
- 11.6.5 Eli Lilly Related Developments
- 11.7 Sanofi
- 11.7.1 Sanofi Corporation Information
- 11.7.2 Sanofi Description and Business Overview
- 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sanofi AT1 Receptor Antagonists Products Offered
- 11.7.5 Sanofi Related Developments
- 11.8 Bristol-Myers Squibb
- 11.8.1 Bristol-Myers Squibb Corporation Information
- 11.8.2 Bristol-Myers Squibb Description and Business Overview
- 11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Products Offered
- 11.8.5 Bristol-Myers Squibb Related Developments
- 11.9 Bayer
- 11.9.1 Bayer Corporation Information
- 11.9.2 Bayer Description and Business Overview
- 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bayer AT1 Receptor Antagonists Products Offered
- 11.9.5 Bayer Related Developments
- 11.10 GSK
- 11.10.1 GSK Corporation Information
- 11.10.2 GSK Description and Business Overview
- 11.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 GSK AT1 Receptor Antagonists Products Offered
- 11.10.5 GSK Related Developments
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer AT1 Receptor Antagonists Products Offered
- 11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 AT1 Receptor Antagonists Market Estimates and Projections by Region
- 12.1.1 Global AT1 Receptor Antagonists Sales Forecast by Regions 2021-2026
- 12.1.2 Global AT1 Receptor Antagonists Revenue Forecast by Regions 2021-2026
- 12.2 North America AT1 Receptor Antagonists Market Size Forecast (2021-2026)
- 12.2.1 North America: AT1 Receptor Antagonists Sales Forecast (2021-2026)
- 12.2.2 North America: AT1 Receptor Antagonists Revenue Forecast (2021-2026)
- 12.2.3 North America: AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
- 12.3 Europe AT1 Receptor Antagonists Market Size Forecast (2021-2026)
- 12.3.1 Europe: AT1 Receptor Antagonists Sales Forecast (2021-2026)
- 12.3.2 Europe: AT1 Receptor Antagonists Revenue Forecast (2021-2026)
- 12.3.3 Europe: AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific AT1 Receptor Antagonists Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: AT1 Receptor Antagonists Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: AT1 Receptor Antagonists Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: AT1 Receptor Antagonists Market Size Forecast by Region (2021-2026)
- 12.5 Latin America AT1 Receptor Antagonists Market Size Forecast (2021-2026)
- 12.5.1 Latin America: AT1 Receptor Antagonists Sales Forecast (2021-2026)
- 12.5.2 Latin America: AT1 Receptor Antagonists Revenue Forecast (2021-2026)
- 12.5.3 Latin America: AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa AT1 Receptor Antagonists Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: AT1 Receptor Antagonists Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: AT1 Receptor Antagonists Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key AT1 Receptor Antagonists Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 AT1 Receptor Antagonists Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on AT1 Receptor Antagonists. Industry analysis & Market Report on AT1 Receptor Antagonists is a syndicated market report, published as Global AT1 Receptor Antagonists Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of AT1 Receptor Antagonists market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
